| scholarly article | Q13442814 |
| P2093 | author name string | Jennifer P Newman | |
| Paula Y P Lam | |||
| Melvin L K Chua | |||
| Kevin L M Chua | |||
| Catherine Y L Kok | |||
| Alan T L Lam | |||
| Shou P Guan | |||
| Siao T Chong | |||
| P2860 | cites work | Signaling molecules and pathways involved in MSC tumor tropism | Q38119884 |
| Determination of IGFs and their binding proteins. | Q38166098 | ||
| Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model. | Q38702903 | ||
| EGFR and IGF-1R in regulation of prostate cancer cell phenotype and polarity: opposing functions and modulation by T-cadherin. | Q38941748 | ||
| Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function. | Q39035362 | ||
| Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel | Q39559581 | ||
| Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice | Q39733970 | ||
| Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. | Q39852557 | ||
| Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLCbeta2 axis | Q39932996 | ||
| Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas | Q39970885 | ||
| HSV-1 amplicon viral vector-mediated gene transfer to human bone marrow-derived mesenchymal stem cells. | Q39974606 | ||
| Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix. | Q40159420 | ||
| MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. | Q40188347 | ||
| PAR-type thrombin receptors in renal carcinoma cells: PAR1-mediated EGFR activation promotes cell migration | Q40307139 | ||
| Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells | Q40371413 | ||
| Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. | Q40512566 | ||
| Insulin-like growth factor (IGF)-independent effects of IGF binding protein-4 on human granulosa cell steroidogenesis | Q44112745 | ||
| The role of G-protein signaling in hematopoietic stem/progenitor cell mobilization. | Q52549424 | ||
| IGF-I and IGF-II stimulate directed cell migration of bone-marrow-derived human mesenchymal progenitor cells. | Q53621706 | ||
| Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells | Q80027788 | ||
| The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities | Q80065296 | ||
| Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions | Q26775038 | ||
| Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology | Q26821929 | ||
| Engineering mesenchymal stem cells for regenerative medicine and drug delivery | Q27026414 | ||
| Cellular actions of the insulin-like growth factor binding proteins | Q28216659 | ||
| The role of the M6P/IGF-II receptor in cancer: tumor suppression or garbage disposal? | Q28262838 | ||
| Insulin-like growth factors and their binding proteins: biological actions | Q28301853 | ||
| The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium | Q28508627 | ||
| A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor | Q33615794 | ||
| The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion | Q33665441 | ||
| Role of insulin receptors and IGF receptors in growth and development | Q33982157 | ||
| Epigenetic Upregulation of Urokinase Plasminogen Activator Promotes the Tropism of Mesenchymal Stem Cells for Tumor Cells | Q34073304 | ||
| Matrix metalloproteinases in tumor invasion and metastasis | Q34136635 | ||
| The insulin-like growth factor system and cancer | Q34200058 | ||
| IGF2 actions on trophoblast in human placenta are regulated by the insulin-like growth factor 2 receptor, which can function as both a signaling and clearance receptor | Q34594074 | ||
| Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells. | Q34884392 | ||
| Directing systemic oncolytic viral delivery to tumors via carrier cells | Q35029126 | ||
| NRD1, which encodes nardilysin protein, promotes esophageal cancer cell invasion through induction of MMP2 and MMP3 expression | Q35051738 | ||
| Insulin-like growth factor binding protein proteolysis | Q35114599 | ||
| IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells | Q35230193 | ||
| Effects of insulin-like growth factor-1 on the properties of mesenchymal stem cells in vitro | Q35653335 | ||
| Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges | Q35838821 | ||
| Regenerative effects of transplanted mesenchymal stem cells in fracture healing | Q36185562 | ||
| Matrix metalloproteinases and cellular motility in development and disease. | Q36452765 | ||
| Mesenchymal stem cells expressing insulin-like growth factor-I (MSCIGF) promote fracture healing and restore new bone formation in Irs1 knockout mice: analyses of MSCIGF autocrine and paracrine regenerative effects. | Q36755738 | ||
| Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells | Q37134013 | ||
| Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells | Q37285238 | ||
| PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways | Q37395771 | ||
| Interactions of IGF-II with the IGF2R/cation-independent mannose-6-phosphate receptor mechanism and biological outcomes. | Q37404002 | ||
| Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma. | Q37407113 | ||
| Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer. | Q37589161 | ||
| Biology and significance of signalling pathways activated by IGF-II. | Q37963987 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 15-26 | |
| P577 | publication date | 2017-11-23 | |
| P1433 | published in | FEBS Open Bio | Q27724062 |
| P1476 | title | Matrix metalloproteinase-1 facilitates MSC migration via cleavage of IGF-2/IGFBP2 complex | |
| P478 | volume | 8 |
Search more.